CPRX vs. SPM.MI
CPRX (Catalyst Pharmaceuticals, Inc.) and SPM.MI (Saipem SpA) are both stocks. CPRX operates in Biotechnology (Healthcare), while SPM.MI operates in Oil & Gas Equipment & Services (Energy). Over the past 10 years, CPRX returned 46.26%/yr vs -4.56%/yr for SPM.MI. At a 0.09 correlation, their price movements are largely independent.
Performance
CPRX vs. SPM.MI - Performance Comparison
Loading charts...
Different Trading Currencies
CPRX is traded in USD, while SPM.MI is traded in EUR. To make them comparable, the SPM.MI values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, CPRX achieves a 34.36% return, which is significantly lower than SPM.MI's 99.31% return. Over the past 10 years, CPRX has outperformed SPM.MI with an annualized return of 46.26%, while SPM.MI has yielded a comparatively lower -4.56% annualized return.
CPRX
- 1D
- -0.03%
- 1M
- 0.64%
- YTD
- 34.36%
- 6M
- 32.77%
- 1Y
- 29.11%
- 3Y*
- 39.03%
- 5Y*
- 40.44%
- 10Y*
- 46.26%
SPM.MI
- 1D
- 0.75%
- 1M
- 5.39%
- YTD
- 99.31%
- 6M
- 107.14%
- 1Y
- 103.87%
- 3Y*
- 63.89%
- 5Y*
- -1.89%
- 10Y*
- -4.56%
CPRX vs. SPM.MI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 34.36% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
SPM.MI Saipem SpA | 99.31% | 17.74% | 60.98% | 34.20% | -76.94% | -22.88% | -44.44% | 30.48% | -18.17% | -18.83% |
Correlation
The correlation between CPRX and SPM.MI is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.15 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2007 | 0.09 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPRX vs. SPM.MI — Risk / Return Rank
CPRX
SPM.MI
CPRX vs. SPM.MI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Saipem SpA (SPM.MI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CPRX | SPM.MI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.32 | ||
| Sortino ratioReturn per unit of downside risk | -2.33 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.47 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | 1.52 | 6.57 | -5.05 |
| Martin ratioReturn relative to average drawdown | 3.46 | 16.45 | -12.99 |
Loading charts...
Drawdowns
CPRX vs. SPM.MI - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, smaller than the maximum SPM.MI drawdown of -99.68%. Use the drawdown chart below to compare losses from any high point for CPRX and SPM.MI.
Loading charts...
Drawdown Indicators
| CPRX | SPM.MI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.25% | -99.68% | +5.43% |
Max Drawdown (1Y)Largest decline over 1 year | -19.18% | -15.80% | -3.38% |
Max Drawdown (3Y)Largest decline over 3 years | -27.29% | -37.94% | +10.65% |
Max Drawdown (5Y)Largest decline over 5 years | -45.37% | -91.64% | +46.27% |
Max Drawdown (10Y)Largest decline over 10 years | -64.87% | -96.37% | +31.50% |
Current DrawdownCurrent decline from peak | -0.03% | -96.60% | +96.57% |
Average DrawdownAverage peak-to-trough decline | -51.96% | -70.53% | +18.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.84% | 6.32% | +3.52% |
Volatility
CPRX vs. SPM.MI - Volatility Comparison
The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 0.47%, while Saipem SpA (SPM.MI) has a volatility of 10.37%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than SPM.MI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPRX | SPM.MI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.47% | 10.37% | -9.90% |
Volatility (6M)Calculated over the trailing 6-month period | 23.17% | 25.74% | -2.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.28% | 32.46% | +0.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.77% | 70.27% | -22.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.39% | 58.04% | +2.35% |
Dividends
CPRX vs. SPM.MI - Dividend Comparison
CPRX has not paid dividends to shareholders, while SPM.MI's dividend yield for the trailing twelve months is around 3.60%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPM.MI Saipem SpA | 3.60% | 7.02% | 0.00% | 0.00% | 0.00% | 0.00% | 0.05% |
Financials
CPRX vs. SPM.MI - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Saipem SpA. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CPRX and SPM.MI have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CPRX and SPM.MI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer